MedPath
HSA Approval

CALPOL SUSPENSION 120 mg/5 ml

SIN06062P

CALPOL SUSPENSION 120 mg/5 ml

CALPOL SUSPENSION 120 mg/5 ml

May 27, 1991

GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.
Licence HolderGSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

N02BE01

paracetamol

Manufacturer Information

gsk consumer healthcare singapore pte. ltd.

Aspen Bad Oldesloe GmbH

Active Ingredients

PARACETAMOL

120 mg/5 ml

Acetaminophen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.